Holdings
Propel Bio Management, LLC
As of Jun 30, 2026, Propel Bio Management, LLC reported 26 positions worth US$179M. Largest: Plains Gp Holdings, L.p., Achieve Life Sciences, Inc. and Corcept Therapeutics Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Plains Gp Holdings, L.p. | 1.27M | US$30.9M | no change | Jun 30, 2026 |
| Achieve Life Sciences, Inc. | 4.03M | US$26.3M | +248K | Jun 30, 2026 |
| Corcept Therapeutics Incorporated | 136K | US$11.9M | −11,329 | Jun 30, 2026 |
| Phathom Pharmaceuticals, Inc. | 1.05M | US$11.4M | +209K | Jun 30, 2026 |
| Delcath Systems, Inc. | 871K | US$11M | −108K | Jun 30, 2026 |
| Milestone Pharmaceuticals Inc. | 7.43M | US$9.96M | +3.31M | Jun 30, 2026 |
| Kyverna Therapeutics, Inc. | 883K | US$7.87M | +239K | Jun 30, 2026 |
| Artiva Biotherapeutics, Inc. | 696K | US$6.76M | +550K | Jun 30, 2026 |
| Abeona Therapeutics Inc. | 983K | US$6.08M | −347K | Jun 30, 2026 |
| Aquestive Therapeutics, Inc. | 1.44M | US$6M | +731K | Jun 30, 2026 |